AAAAAA
Results: 1-25/83
Authors:
Van de Werf, F
Citation: F. Van De Werf, New aspects of pharmacological reperfusion: from macro- to microlysis, EUR H J SUP, 3(C), 2001, pp. C62-C68
Authors:
Holvoet, P
Mertens, A
Verhamme, P
Bogaerts, K
Beyens, G
Verhaeghe, R
Collen, D
Muls, E
Van de Werf, F
Citation: P. Holvoet et al., Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease, ART THROM V, 21(5), 2001, pp. 844-848
Authors:
Ni, Y
Pislaru, C
Bosmans, H
Pislaru, S
Miao, Y
Bogaert, J
Dymarkowski, S
Yu, J
Semmler, W
Van de Werf, F
Baert, AL
Marchal, G
Citation: Y. Ni et al., Intracoronary delivery of Gd-DTPA and Gadophrin-2 for determination of myocardial viability with MR imaging, EUR RADIOL, 11(5), 2001, pp. 876-883
Authors:
D'hooge, J
Schrooten, M
Bijnens, B
Thoen, J
Van de Werf, F
Sutherland, G
Suetens, P
Citation: J. D'Hooge et al., Parametric study of the peak negative acoustic pressure distribution within the image plane of a phased array transducer, IEEE ULTRAS, 48(4), 2001, pp. 1092-1102
Authors:
Kaul, P
Fu, YL
Chang, WC
Harrington, RA
Wagner, GS
Goodman, SG
Granger, CB
Moliterno, DJ
Van de Werf, F
Califf, RN
Topol, EJ
Armstrong, PW
Citation: P. Kaul et al., Prognostic value of ST segment depression in acute coronary syndromes: Insights from PARAGON-A applied to GUSTO-IIb, J AM COL C, 38(1), 2001, pp. 64-71
Authors:
Maes, AF
Van de Werf, F
Mesotten, LV
Flamen, PB
Kuzo, RS
Nuyts, JL
Mortelmans, L
Citation: Af. Maes et al., Early assessment of regional myocardial blood flow and metabolism in thrombolysis in myocardial infarction flow grade 3 reperfused myocardial infarction using carbon-11-acetate, J AM COL C, 37(1), 2001, pp. 30-36
Authors:
Mesotten, L
Maes, A
Herregods, MC
Desmet, W
Nuyts, J
Van de Werf, F
Mortelmans, L
Citation: L. Mesotten et al., PET "reversed mismatch pattern" early after acute myocardial infarction: follow-up of flow, metabolism and function, EUR J NUCL, 28(4), 2001, pp. 466-471
Authors:
Coussement, PK
Bassand, JP
Convens, C
Vrolix, M
Boland, J
Grollier, G
Michels, R
Vahanian, A
Vanderheyden, M
Rupprecht, HJ
Van de Werf, F
Citation: Pk. Coussement et al., A synthetic factor-Xa inhibitor (ORG31540/SR9017A) as an adjunct to fibrinolysis in acute myocardial infarction - The PENTALYSE study, EUR HEART J, 22(18), 2001, pp. 1716-1724
Authors:
Lesaffre, E
Bluhmki, E
Wang-Clow, F
Berioli, S
Danays, T
Fox, NL
Van de Werf, F
Citation: E. Lesaffre et al., The general concepts of an equivalence trial, applied to ASSENT-2, a large-scale mortality study comparing two fibrinolytic agents in acute myocardial infarction, EUR HEART J, 22(11), 2001, pp. 898-902
Authors:
Willems, R
Ector, H
Holemans, P
Van de Werf, F
Heidbuchel, H
Citation: R. Willems et al., Effect of different pacing protocols on the induction of atrial fibrillation in a transvenously paced sheep model, PACE, 24(6), 2001, pp. 925-932
Authors:
Van de Werf, F
Armstrong, PW
Granger, C
Wallentin, L
Citation: F. Van De Werf et al., Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction, LANCET, 358(9282), 2001, pp. 605-613
Authors:
Topol, EJ
Califf, RM
Van de Werf, F
Willerson, JT
Booth, J
White, H
Clayman, M
Deckelbaum, L
Lincoff, AM
Ohman, EM
Bates, E
Gibler, WB
Hochman, J
Kleiman, N
Grinfeld, L
Aylward, P
Armstrong, PW
Heikkila, J
Vahanian, A
Steg, G
Bode, C
Adgy, AAJ
Guetta, V
Ardissino, D
Savonitto, S
Bar, F
Simoons, M
Kontny, F
White, H
Sadowski, Z
Seabra-Gomes, R
Dalby, A
Betriu, A
Swahn, E
Wilcox, R
Frye, RL
Bertrand, ME
DeMets, D
Fox, KKA
Fuster, V
Lee, KL
McCarthy, C
Waller, M
Scherer, J
van de Kerkhove, A
Kukulewicz, L
Booth, JE
Del Valle, M
Hibert, D
Brannon, D
Citation: Ej. Topol et al., Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO randomised trial, LANCET, 357(9272), 2001, pp. 1905-1914
Authors:
Sinnaeve, P
Van de Werf, F
Citation: P. Sinnaeve et F. Van De Werf, Thrombolytic therapy - State of the art, THROMB RES, 103, 2001, pp. S71-S79
Authors:
Alpert, JS
Thygesen, K
Antman, E
Bassand, JP
Apple, F
Armstrong, PW
Bassand, JP
de Luna, AB
Beller, G
Breithardt, G
Chaitman, BR
Clemmensen, P
Falk, E
Fishbein, MC
Galvani, M
Garson, A
Grines, C
Hamm, C
Hoppe, U
Jaffe, A
Katus, H
Kjekshus, J
Klein, W
Klootwijk, P
Lenfant, C
Levy, D
Levy, RI
Luepker, R
Marcus, F
Naslund, U
Ohman, M
Pahlm, O
Poole-Wilson, P
Popp, R
Pyorala, J
Ravkilde, J
Rehnquist, N
Roberts, W
Roberts, R
Roelandt, J
Ryden, L
Sans, S
Simoons, ML
Thygesen, K
Tunstall-Pedoe, H
Underwood, R
Uretsky, BF
Van de Werf, F
Voipio-Pulkki, LM
Wagner, G
Wallentin, L
Wijns, W
Wood, D
Sendon, JLL
Tendera, M
Citation: Js. Alpert et al., Myocardial infarction redefined - A consensus document of the joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction (Reprinted from J Am Coll Cardiol, vol36, pg 959-69, 2000), CLIN CHEM, 47(3), 2001, pp. 382-392
Authors:
Jamal, F
Strotmann, J
Weidemann, F
Kukulski, T
D'hooge, J
Bijnens, B
Van de Werf, F
De Scheerder, I
Sutherland, GR
Citation: F. Jamal et al., Noninvasive quantification of the contractile reserve of stunned myocardium by ultrasonic strain rate and strain, CIRCULATION, 104(9), 2001, pp. 1059-1065
Authors:
Fu, YL
Goodman, S
Chang, WC
Van de Werf, F
Granger, CB
Armstrong, PW
Citation: Yl. Fu et al., Time to treatment influences the impact of ST-segment resolution on one-year prognosis - Insights from the Assessment of the Safety and Efficacy of aNew Thrombolytic (ASSENT-2) trial, CIRCULATION, 104(22), 2001, pp. 2653-2659
Authors:
Armstrong, PW
Granger, C
Van de Werf, F
Citation: Pw. Armstrong et al., Bolus fibrinolysis - Risk, benefit, and opportunities, CIRCULATION, 103(8), 2001, pp. 1171-1173
Authors:
Barbash, GI
Birnbaum, Y
Bogaerts, K
Hudson, M
Lesaffre, E
Fu, YL
Goodman, S
Houbracken, K
Munsters, K
Granger, CB
Pieper, K
Califf, RM
Topol, EJ
Van de Werf, F
Citation: Gi. Barbash et al., Treatment of reinfarction after thrombolytic therapy for acute myocardial infarction - An analysis of outcome and treatment choices in the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO I) and assessment of the safety of a new thrombolytic(ASSENT 2) studies, CIRCULATION, 103(7), 2001, pp. 954-960
Authors:
Newby, LK
Ohman, EM
Christenson, RH
Moliterno, DJ
Harrington, RA
White, HD
Armstrong, PW
Van de Werf, F
Pfisterer, M
Hasselblad, V
Califf, RM
Topol, EJ
Citation: Lk. Newby et al., Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin T-positive status - The PARAGON-B troponin T substudy, CIRCULATION, 103(24), 2001, pp. 2891-2896
Authors:
Angeja, BG
Alexander, JH
Chin, R
Li, X
Barron, HV
Armstrong, PW
Granger, CB
Van de Werf, F
Gibson, CM
Citation: Bg. Angeja et al., Safety of the weight-adjusted dosing regimen of tenecteplase in the ASSENT-trial, AM J CARD, 88(11), 2001, pp. 1240-1245
Authors:
Van de Werf, F
Citation: F. Van De Werf, New data in treatment of acute coronary syndromes, AM HEART J, 142(2), 2001, pp. S16-S21
Authors:
Lundergan, CF
Ross, AM
McCarthy, WF
Reiner, JS
Boyle, D
Fink, C
Califf, RM
Topol, EJ
Simoons, ML
Van Den Brand, M
Van de Werf, F
Coyne, KS
Citation: Cf. Lundergan et al., Predictors of left ventricular function after acute myocardial infarction:Effects of time to treatment potency, and body mass index - The GUSTO-I angiographic experience, AM HEART J, 142(1), 2001, pp. 43-50
Authors:
Giugliano, RP
McCabe, CH
Antman, EM
Cannon, CP
Van de Werf, F
Wilcox, RG
Braunwald, E
Citation: Rp. Giugliano et al., Lower-dose heparin with fibrinolysis is associated with lower rates of intracranial hemorrhage, AM HEART J, 141(5), 2001, pp. 742-750
Authors:
de Lemos, JA
Gibson, CM
Antman, EM
Murphy, SA
Morrow, DA
Schuhwerk, KC
Schweiger, M
Coussement, P
Van de Werf, F
Braunwald, E
Citation: Ja. De Lemos et al., Abciximab and early adjunctive percutaneous coronary intervention are associated improved ST-segment resolution after thrombolysis: Observations fromthe TIMI 14 trial, AM HEART J, 141(4), 2001, pp. 592-598
Authors:
Agnelli, G
Avezum, A
Brieger, D
Budaj, A
Cannon, CP
Goldberg, RJ
Goodman, S
Gulba, DC
Granger, C
Kennelly, BM
Gurfinkel, E
Lopez-Sendon, J
Klein, W
Montalescot, G
Van de Werf, F
Citation: G. Agnelli et al., Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project: A multinational registry of patients hospitalized with acute coronary syndromes, AM HEART J, 141(2), 2001, pp. 190-199